Neuropeptide Y in PTSD, MDD, and chronic stress: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neuroscience Research"
DOI: 10.1002/jnr.24589
Abstract: Previous studies have suggested that neuropeptide Y (NPY) levels may be altered in patients with major depressive disorder (MDD), post‐traumatic stress disorder (PTSD) and chronic stress. We investigated, through systematic review and meta‐analysis, whether the… read more here.
Keywords: npy levels; chronic stress; stress; ptsd mdd ... See more keywords
The role of neuropeptide Y, orexin-A, and ghrelin in differentiating unipolar and bipolar depression: a preliminary study
Sign Up to like & getrecommendations! Published in 2022 at "Nordic Journal of Psychiatry"
DOI: 10.1080/08039488.2022.2048887
Abstract: Abstract Background When depressive symptoms in bipolar and unipolar patients were compared, a number of studies reported that atypical vegetative features such as hypersomnia and hyperphagia were more common in bipolar patients. Moreover, neuropeptides such… read more here.
Keywords: unipolar bipolar; depression; ghrelin; npy levels ... See more keywords
Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn reduce NPY levels via muscarinic receptor activation
Sign Up to like & getrecommendations! Published in 2025 at "Cardiovascular Research"
DOI: 10.1093/cvr/cvaf180
Abstract: Abstract Aims Ventricular arrhythmias are associated with sympathoexcitation and increased co-transmitter neuropeptide Y (NPY) levels. Vagal nerve stimulation (VNS) has been reported to decrease release of norepinephrine, while NPY has been reported to decrease acetylcholine… read more here.
Keywords: receptor; activation; levels via; npy levels ... See more keywords